Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prebona is a Swedish public nanotechnology and smart-materials company developing and commercializing surface-modified silica formulations for odor control, antimicrobial protection, surface care, textile care, agriculture, and healthcare applications. Its technology attaches active atoms or molecules to silica particles at the atomic level to create functional materials with properties such as odor elimination, hygiene support, nutrient delivery, and surface protection. Within healthcare, the company markets products such as Inodorus OdorCare for hospitals, elderly care, wound care, and incontinence-related applications, and it has reported procurement wins and reimbursement-related progress in the Nordic region. Prebona appears to be primarily a commercial materials and product company rather than a therapeutics developer, with healthcare as one of several end markets. The business is publicly traded in Sweden and positions sustainability, water-based formulations, and low-environmental-impact manufacturing as core differentiators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prebona.